Crossmark

Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population

Published Online: 2018-07-27

Published Print: 2018-12

Authors

Kochar, Inderpal Singh http://orcid.org/0000-0001-9124-8164
Sethi, Aashish
License Information

Text and Data Mining valid from 2018-07-27
More Information

Article History

Received: 31 January 2018

Accepted: 9 July 2018

First Online: 27 July 2018

Ethics approval and consent to participate

: The study was initiated after taking an approval from institutional ethics committee (Apollo Hospital, Delhi) and was conducted in accordance with principals of the Declaration of Helsinki and ICH Good Clinical Practice. Informed written Consent was taken from Parents before enrolling the child in study.Clinical Study Reference Application Number: IAH/076/02-17Name of Ethics Committee: Institutional Ethics Committee-Clinical Studies, Indraprastha Apollo Hospital, New Delhi, IndiaEthics Committee Registration Number : ECR/5/Inst/DI/2013Date of Approval: 3rd March, 2017

: This article does not include any individual participant’s data in any form. Informed written consent was taken from Parents before enrolling the child in study.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current